ASCL1 and prostate carcinoma: Apparently dedifferentiated prostate cancer cells may, therefore, retain aspects of NE transdifferentiation post-AD, such as persistent hASH1 signalling capacity, and exist in a hybrid state between NE-like and epithelial-like phenotypes.